Nadeem R Abu-Rustum, Catheryn M Yashar, Rebecca Arend, Emma Barber, Kristin Bradley, Rebecca Brooks, Susana M Campos, Junzo Chino, Hye Sook Chon, Marta Ann Crispens, Shari Damast, Christine M Fisher, Peter Frederick, David K Gaffney, Stephanie Gaillard, Robert Giuntoli, Scott Glaser, Jordan Holmes, Brooke E Howitt, Kari Kendra, Jayanthi Lea, Nita Lee, Gina Mantia-Smaldone, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Mirna Podoll, Kerry Rodabaugh, Ritu Salani, John Schorge, Jean Siedel, Rachel Sisodia, Pamela Soliman, Stefanie Ueda, Renata Urban, Stephanie L Wethington, Emily Wyse, Kristine Zanotti, Nicole McMillian, Sara Espinosa
Vulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of gynecologic malignancies. Known risk factors for vulvar cancer include increasing age, infection with human papillomavirus, cigarette smoking, inflammatory conditions affecting the vulva, and immunodeficiency. Most vulvar neoplasias are diagnosed at early stages. Rarer histologies exist and include melanoma, extramammary Paget's disease, Bartholin gland adenocarcinoma, verrucous carcinoma, basal cell carcinoma, and sarcoma...
March 2024: Journal of the National Comprehensive Cancer Network: JNCCN